EXPERIMENTAL DRUG DEVELOPMENT CENTRE

Business Description

EXPERIMENTAL DRUG DEVELOPMENT CENTRE is registered as a business entity on 13 April 2007 (17.9 years ago) structured as a Sole Proprietor with 1 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 53090262A. The business official address is located at 20 Biopolis Way #07-01, Centros, Singapore 138668 with main trading activity as Enhance Development Of Biomedical Research Into Commercializable Products in the primary industry of 72106: Research And Experimental Development On Medical Science using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as EXPERIMENTAL THERAPEUTICS CENTRE. The business annual account filing date falls on 13 April and is currently operational with the status of 'Live'.

In the past 365 days, EXPERIMENTAL DRUG DEVELOPMENT CENTRE has received a total of Login to view reported payment review(s). 19 were rated Good and Login to view were rated Poor. The latest review was made on 2023-05-16 and it was reported "Good". The aggregated good payment amount is equivalent to USD 8,455, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is currently active, it also signals positive financial standing. The lack of an appointed auditor indicates that the business is small sized as it did not meet the regulatory requirements of revenue or assets exceeding SGD 10 million, or has more than 50 employees in the previous two fiscal years.

EXPERIMENTAL DRUG DEVELOPMENT CENTRE is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023